 Analgesics
|
|
Anesthetics
|
|
Anti-Addiction / Substance Abuse Treatment Agents
|
|
Antibacterials
|
|
Anticonvulsants
|
|
Antidementia Agents
|
|
 Antidepressants
|
Monoamine Oxidase Inhibitors
|
Serotonin / Norepinephrine Reuptake Inhibitors
|
Tricyclics
|
Antidepressants, Other
|
Bupropion
|
Maprotiline
|
Mirtazapine
|
Nefazodone
|
Trazodone
|
Augmentation Agents
|
Aripiprazole
|
Quetiapine
|
 D08456 Quetiapine (INN)
D00458 Quetiapine fumarate (JAN/USAN)
|
|
Antiemetics
|
|
Antifungals
|
|
Antigout Agents
|
|
Anti-inflammatory Agents
|
|
Antimigraine Agents
|
|
Antimyasthenic Agents
|
|
Antimycobacterials
|
|
Antineoplastics
|
|
Antiparasitics
|
|
Antiparkinson Agents
|
|
Antipsychotics
|
1st Generation/Typical
|
2nd Generation/Atypical
|
Aripiprazole
|
Asenapine
|
Iloperidone
|
Lurasidone
|
Olanzapine
|
Quetiapine
|
D08456 Quetiapine (INN)
D00458 Quetiapine fumarate (JAN/USAN)
|
Paliperidone
|
Risperidone
|
Ziprasidone
|
Treatment-Resistant
|
|
Antispasticity Agents
|
|
Antivirals
|
|
Anxiolytics
|
|
Bipolar Agents
|
Mood Stabilizers
|
Bipolar Agents, Other
|
Aripiprazole
|
Asenapine
|
Olanzapine
|
Quetiapine
|
D08456 Quetiapine (INN)
D00458 Quetiapine fumarate (JAN/USAN)
|
Risperidone
|
Ziprasidone
|
|
Blood Glucose Regulators
|
|
Blood Products / Modifiers / Volume Expanders
|
|
Cardiovascular Agents
|
|
Central Nervous System Agents
|
|
Dental and Oral Agents
|
|
Dermatological Agents
|
|
Enzyme Replacement / Modifying Agents
|
|
Gastrointestinal Agents
|
|
Genitourinary Agents
|
|
Hormonal Agents
|
|
Immunological Agents
|
|
Inflammatory Bowel Disease Agents
|
|
Metabolic Bone Disease Agents
|
|
Ophthalmic Agents
|
|
Otic Agents
|
|
Respiratory Tract Agents
|
|
Skeletal Muscle Relaxants
|
|
Sleep Disorder Agents
|
|
Therapeutic Nutrients / Minerals / Electrolytes
|
USP Drug Classification